Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

SPI-1620

Known as: Endothelin B Receptor Agonist SPI-1620 
A highly selective peptide agonist of the endothelin-B receptor. Endothelin B receptor agonist SPI-1620 binds to endothelin-B receptors on… Expand
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Background:This multicentre, open-label study evaluated the efficacy and safety of SPI-1620, an analogue of endothelin-1… Expand
  • table 1
  • table 2
  • table 4
  • figure 1
  • table 3
2012
2012
ETB receptor agonist, IRL-1620 (or SPI-1620) presently in US Phase 1 clinical trial, has been demonstrated to selectively and… Expand
  • figure 1
  • figure 2
2009
2009
AACR Annual Meeting-- Apr 18-22, 2009; Denver, CO Aim : The ETB receptor peptide agonist, SPI-1620, has been demonstrated to… Expand
2007
2007
B3 Background: SPI-1620 (also known as IRL-1620) is a selective ETB receptor agonist that has been reported to selectively… Expand